Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study

Metabolism: Clinical and Experimental

Volumn 57, Issue 3, 2008, Pages 399-403

  Valdés, Sergio ^a,b   Botas, Patricia ^c   Delgado, Elías ^a   Álvarez, Francisco ^a   Cadórniga, Francisco Diaz ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL SAN AGUSTÍN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POPULATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERENCE STANDARDS; RISK FACTORS; ROC CURVE; SPAIN;

EID: 38749100661     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.10.017     Document Type: Article

References (23)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva
3. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
4. Borch-Johnsen K., Colagiuri S., Balkau B., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47 (2004) 1396-1402
5. Forouhi N.G., Balkau B., Borch-Johnsen K., et al., on behalf of EDEG. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 49 (2006) 822-827
6. Valdes S., Botas P., Delgado E., Diaz-Cadorniga F.J., and Alvarez F. Population-based incidence of type 2 diabetes in northern Spain. The "Asturias Study". Diabetes Care 30 (2007) 2258-2263
7. Valdes S., Rojo-Martinez G., and Soriguer F. Evolution of prevalence of type 2 diabetes in the adult Spanish population. Med Clin (Barc) 129 (2007) 352-355
8. DeVegt F., Dekker J., Jager A., et al. Relation of impaired fasting and post-load glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285 (2001) 2109-2113
9. Lyssenko V., Almgren P., Anevski D., et al., for the Botnia Study Group. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54 (2005) 166-174
10. Gabir M.M., Hanson R.L., Dabelea D., et al. The 1997 American Diabetes Association and the 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23 (2000) 1108-1111
11. Shaw J.E., Zimmet P.Z., De Courten M., et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?. Diabetes Care 22 (1999) 399-402
12. Lorenzo C., Okoloise M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as a predictor of type 2 diabetes. The San Antonio Heart Study. Diabetes Care 26 (2003) 3153-3159
13. Unwin N., Shaw J., Zimmet P., and Alberty K.G.M.M. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19 (2002) 708-723
14. Shaw J.E., Zimmet P.Z., Hodge A.M., et al. Impaired fasting glucose: how low should it go?. Diabetes Care 23 (2000) 34-39
15. Ryu S., Shin H., Chang Y., Sung K.C., Song J., and Lee S.J. Should the lower limit of impaired fasting glucose be reduced from 110 mg/dL in Korea?. Metabolism 55 (2006) 489-493
16. Nichols G.A., Hillier T.A., and Brown J.B. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care 30 (2007) 228-233
17. Pan X.R., Li G.W., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care 20 (1997) 537-544
18. Tuomilehto J., Lindstrom J., Eriksson J.G., et al., for the Finish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
19. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
20. Nathan D.M., Davidson M.B., DeFronzo R.A., et al. Impaired fasting glucose and impaired glucose tolerance. Implications for care. Diabetes Care 30 (2007) 753-759
21. Sorkin J.D., Muller D.C., Fleg J.L., and Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality. Data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28 (2005) 2626-2632
22. DeVegt F., Dekker J.M., Ruhe H.G., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931
23. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164 (2004) 2147-2155